 Taysha Gene Therapies NASDAQ:TSHA has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 1 0 1 Somewhat Bullish 0 2 1 1 Indifferent 0 0 0 Somewhat Bearish 0 0 0 Bearish 0 0 0 9 analysts offering 12-month price targets in the last 3 months for Taysha Gene Therapies evaluate the company at an average price target of 46.61 with a high of 67.50 and a low of 30.00. 